galanin

is a neuropeptide that has been implicated in Alzheimer's, as well as depression and eating disorders. Considerably more than usual is produced in the early stages of Alzheimer’s, possibly as a response to the deterioration of brain cells. While this might help initially, as the disease progresses, the overexpression of galanin may become its own problem, contributing to cognitive decline.